A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of a Cream Containing Xyloglucan, Pea Protein, and Opuntia Ficus-Indica Extract Versus Calcipotriol/Betamethasone in Adult Patients with Mild-to-Moderate Psoriasis.

    March 2024 in “ PubMed ”
    Stefano Veraldi, Valentina Rosca, Remus Orăsan, María Magdalena Constantin, Roni P. Dodiuk‐Gad

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →